Stock Watch: J&J, GSK, Lilly Bring J.P. Morgan Cheer
But Full-Year Revenue Announcements Offset Acquisitions Buzz
After a less auspicious prelude and a positive start to the biggest healthcare conference of the year, the news flow and investors’ support for biotech initially improved.
